the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Former bank sales head fined RM90,000 for bribery

A former bank employee was fined RM90,000 after pleading guilty to 17 bribery and non-reporting charges linked to housing loan referrals.

MELAKA: A former bank employee was fined a total of RM90,000 by the Ayer Keroh Sessions Court here today after pleading guilty to 17 charges involving bribery and failure to report corrupt payments linked to housing loan referrals.

Judge Elesabet Paya Wan imposed the sentence on Mohd Rais Mohamed Ramli, 44, and ordered him to serve between two and 10 months’ imprisonment for each charge if he fails to pay the fine.

According to the charges, Mohd Rais, then the bank’s regional sales head, had accepted bribes amounting to RM123,132.50 from a law firm through his wife’s company account.

The payments, ranging from RM2,820 to RM15,545, were allegedly given as an inducement for helping the law firm secure referrals for housing loan cases through a bank executive officer under his supervision.

The offences were committed at a bank branch in Taman Seri Gombak, Batu Caves, Selangor, between Dec 13, 2019 and Jan 27, 2023.

He was charged under Section 16(a)(A) of the Malaysian Anti-Corruption Commission (MACC) Act 2009 for accepting bribes, as well as Section 25(1) of the same Act for failing to report the bribes to MACC officers or the nearest police station.

Earlier, during mitigation, defence counsel S.S. Amritpal Singh said his client, who has no permanent job, has a wife and three children to support.

MACC deputy public prosecutor Sharina Farhana Nor Sa’ari appeared for the prosecution.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings